Palifermin Prophylaxis

Palifermin Prophylaxis is a clinical intervention strategy involving the administration of recombinant human keratinocyte growth factor to mitigate the severity and duration of oral mucositis in high-risk patients undergoing hematopoietic stem cell transplantation.

16

Publications

572

Citations

110

Authors

67

Institutions

Publications per year

2017–2026

1

Publications

16

1–5 of 16

Authors

110

  1. RS
    Ricardo Spielberger

    City Of Hope National Medical Center, United States

    3 publications · 94 citations

    3

    h-index

  2. AL
    Alessandra Lucchese

    Vita-Salute San Raffaele University, Italy

    2 publications · 93 citations

    2

    h-index

  3. JL
    James L.M. Ferrara

    University of Michigan, United States

    2 publications · 199 citations

    2

    h-index

  4. MM
    Maurizio Manuelli

    Vita-Salute San Raffaele University, Italy

    2 publications · 93 citations

    2

    h-index

  5. PJ
    Patrick J. Stiff

    Loyola University Medical Center, United States

    2 publications · 76 citations

    2

    h-index

1–5 of 110

Venues

  1. Biology of Blood and Marrow Transplantation

    TCT · 4 publications · 161 citations

    4

    h-index

  2. PubMed

    Repository · 2 publications · 61 citations

    2

    h-index

  3. Blood

    2 publications · 156 citations

    2

    h-index

  4. Bone Marrow Transplantation

    2 publications · 46 citations

    2

    h-index

  5. Supportive Care in Cancer

    1 publications · 18 citations

    1

    h-index

1–5